Scleroderma News

To mark awareness month and educate others this June, the National Scleroderma Foundation has launched a campaign dubbed "Beacons of Hope." https://buff.ly/6JRC3GT

The experimental scleroderma therapy BLR-200 showed promise in a mouse model to prevent the disease’s characteristic tissue scarring. https://buff.ly/07Ulrjy

Researchers have identified a molecular pathway in skin cells that may be involved in inflammation and scarring in scleroderma, per a study. https://buff.ly/0IY1oQG

Sex-specific genetic findings may offer clues into why systemic sclerosis affects women and men differently, a new study suggests. https://buff.ly/4r10tmj

In SSc without overlap syndrome, specific autoantibodies were tied to symptoms, while non-specific antibodies showed limited clinical value. https://buff.ly/PxJUX0X

Blood levels of the liver enzyme ALT are the most accurate predictor of AIH in people with systemic sclerosis, a study in Turkey shows. https://buff.ly/BlU0lgV

Autologous stem cell transplant was effective for controlling scleroderma in a teenager with severe disease. https://buff.ly/3iQ4nNp

A genetic analysis identified existing medications that could be repurposed as potential scleroderma treatment options, a new study reports. https://sclerodermanews.com/news/study-suggests-existing-therapies-aid-scleroderma-treatment/

Levels of anti-CD146 antibodies may help identify SSc associated with occupational exposure to silica and other mineral dusts, a study found. https://buff.ly/qXbavwt

The scleroderma drug AISA-021 safely reduced Raynaud’s attack frequency and duration in a study but still failed to meet its primary goal. https://buff.ly/KgOA4Do